NEW DELHI, Nov 11 (Thomson Reuters Foundation) - Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its 1.3 billion population and ...
<div><strong><em>By CH Unnikrishnan</em></strong></div><div> </div><div>Pfizer Ltd, the Indian arm of US drugmaker Pfizer Inc, said on Wednesday that it has ...
Cipla Ltd. has inked an exclusive agreement with Pfizer India to market, distribute, and sell the latter's four brands across the country. Under the agreement, Cipla now has the sole right to market, ...
Novartis exits India's mass-market generics, signalling a deeper split between MNC innovation bets and domestic pharma scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results